Key result
A 12-week individualized exercise training program significantly reduced ambulatory blood pressure and improved exercise tolerance in heart transplant patients, with greater benefits seen in those with cardiac reinnervation.
Why the study?
Does a 12-week exercise training program improve ambulatory blood pressure and exercise tolerance in heart transplant patients, and does cardiac reinnervation influence these outcomes?
Does a 12-week exercise training program improve ambulatory blood pressure and exercise tolerance in heart transplant patients, and does cardiac reinnervation influence these outcomes?
Answers are grounded in this paper and cite their sources.
A 12-week exercise training program improves ambulatory blood pressure and exercise tolerance in pediatric and young adult heart transplant patients, with greater benefits observed in those with cardiac reinnervation.
It is already a long time since a new and challenging therapy for incurable end-stage heart failure was developed. The first cardiac transplant was performed by the South African cardiac surgeon Christian Barnard on 3 December 1967.1 Since then, this innovative and complex invasive cardiac therapeutic approach has been increasingly used around the world, reaching, on average, more than 5,000 end-stage terminal heart failure patients a year, and extraordinarily extending their survival, especially in more recent times.2 According to the European Society of Cardiology (ESC) statement published in 2016,3 heart transplantation is indicated for patients with end-stage heart failure with severe symptoms, a low maximum oxygen consumption (VO2max), a poor prognosis, and no other new alternative treatment options, such as cardiac resynchronization therapy and/or drugs. In addition, these patients should be motivated, well-informed, emotionally stable, and also capable of complying with the intensive treatment and rehabilitation required postoperatively. In this context, orthotopic heart transplantation is currently widely accepted as an effective alternative for individuals with end-stage heart failure. It is also very clinically relevant that patients who have been submitted to heart transplantation, and do not have major acute phase problems such as rejection, do not only live longer but also have a substantial improvement in their health-related quality of life after transplantation. These favorable results are most likely due to a combination of new drugs and techniques and also result from better understanding of the relevance of adequate diet and regular exercise training, all of which help lead to a healthier life. While heart transplant patients have been attending formal exercise training programs at least since the 1980s,4 in some cases showing extreme exercise performance such as successfully completing a marathon 27 years after a heart transplant or completing one-year of high intensity training,5 information remains scanty about the ability of heart transplant patients to participate in exercise training and how they finally respond to regular exercise interventions. Indeed, by searching PubMed recently using the keywords “cardiac transplantation” AND “exercise training” only 29 articles could be found in mid-September 2019. In this context, the study by Ciolac et al.6 being published in the journal should be very welcome. The authors recruited their 35 heart transplant patients – aged from 6–20 years old – from a single medical center. The study authors purposely selected those who had undergone cardiac surgery at least one year ago and were clinically stable and physically inactive. Cardiopulmonary exercise testing (CPX) data obtained one to two weeks before were used to provide individualized aerobic exercise prescription. In addition to aerobic exercise, resistance and flexibility exercises were also included in the sessions of a 12-week (three times a week) training program. The authors carefully controlled for several potentially confounding variables such as, for example, by having the patients carry out exercise always at the same time of the day, using proper equipment and methods for assessing major variables in order to minimize the possibility of inter- and intra- observer error in blood pressure measurements undertaken in the exercise sessions and 24-hour ambulatory mode. Using established definition criteria, the patients were divided into two groups based on presenting or not presenting evidence of cardiac reinnervation. For this separation, three criteria were assessed and at least of two of them – all related to heart rate response to exercise and at first minute of recovery – needed to be fulfilled to classify the patients who had some degree of cardiac reinnervation. Interestingly, the authors have performed a very successful study here as there were only two dropouts in this quite ambitious exercise intervention protocol. We greatly appreciate and acknowledge that the authors have currently shown that exercise training was effective to significantly reduce ambulatory blood pressure in the heart transplant patients with cardiac reinnervation presenting greater favorable changes.5 In addition, based on exercise tolerance and measured VO2max data, heart transplant patients that had some degree of cardiac reinnervation benefited from a 12-week comprehensive and individualized exercise training program. Considering the large body of evidence clearly indicating that low cardiorespiratory (aerobic) fitness is a risk factor for death,7 this is an important finding of this study and may favorably impact on the survival curves of these patients. For those used to reading scientific literature on CPX and particularly in heart failure patients, it may seem unusual that exercise testing was carried out on a treadmill and, even rarer, using the Naughton protocol rather than a ramp-like protocol on the cycle ergometer.8 On the other hand, since the aerobic component of the exercise section was carried out by treadmill walking, it might have been a good choice to test-retest the patients using a maximal treadmill test. At this stage, it can only be speculated what would have been the results if a very safe ramp protocol using cycling exercise with reliable hemodynamic and ventilatory measurements had been used for both training and testing. From a physiological point-of-view, it would be interesting to have analyzed the role of the oxygen pulse (VO2/heart rate), a surrogate for stroke volume, evaluating both the curve profile and maximal relative to body weight value,9 during test-retest CPX. It would also have been potentially informative to compare both groups of patients regarding this variable. Finally, future studies should be focusing on identifying the best exercise intervention mode and duration for heart transplant patients and to answer the relevant question, whether exercise training intervention should also be tailored according to the presence or absence of cardiac reinnervation in these patients. The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The author(s) received no financial support for the research, authorship, and/or publication of this article.
No takes yet. Share an insight, caveat, or question.
Araújo et al. (2019) conducted an editorial in Heart transplant (n=35). Individualized exercise training program (aerobic, resistance, and flexibility) vs. Patients without evidence of cardiac reinnervation (comparison based on reinnervation status) was evaluated on Ambulatory blood pressure and exercise tolerance (VO2max). A 12-week individualized exercise training program significantly reduced ambulatory blood pressure and improved exercise tolerance in heart transplant patients, with greater benefits seen in those with cardiac reinnervation.
Synapse has enriched 10 related papers. Consider them for comparative context: